Schematic illustration of the staining patterns for ALK and the N- and C-terminal portions of NPM in lymphomas carrying NPM-ALK or variant ALK fusion protein(s). Further details of the reactivity of the anti-NPM monoclonal antibodies have been published elsewhere.31